Soon the Recovery will Likely be the Rule and Death will be an Exception in COVID-19
Abstract
Since the cluster of cases of SARS-CoV-2 first reported in December 2019, the number of COIVD-19 cases have rapidly been increasing and deaths too but cumulative percentage of deaths have been decreasing since the April 2020 both worldwide and South Asian countries. Knowing the number of reported deaths during a period of the pandemic is not enough but knowing the number of excess deaths in a given population over the time may carry weight which is yet to be known globally. Also, the COVID-19 pandemic may lead to increased deaths from some other communicable diseases such as TB, dengue, and fewer deaths from some other causes such as road accidents. Hence, both reported mortality figures and excess mortality figures are required to understand the death toll of the pandemic COVID-19. Around one third patients are asymptomatic transmitting infection and among symptomatic, 80% mild to moderate disease managed as outpatients in home isolation; 15% develop lower respiratory tract infection require hospitalization and recover; 3-5% require intensive care and may need ventilator support and 0.5-1% of patients will die. We are of the opinion that in case of COVID-19, soon the recovery will likely be the rule and death will be an exception and our opinion is based on the facts of better understanding of COVID-19 infection and disease and its prevention, control and supportive treatment strategy even in absence efficacious vaccine for prevention and effective medicine for cure and prophylaxis. The condition is that if continue to follow non-pharmacological interventions for containment and mitigation with true public health spirit.
References
COVID-19- Coronavirus Pandemic. https://www.worldometers.info/coronavirus/ Accessed on October 17, 2020
Highlights and Situation Overview COVID-19 cases in the SAARC Member States http://www.covid19-sdmc.org Accessed on October 17, 2020
Piryani RM, Piryani S, Shah JN. Nepal’s Response to Contain COVID-19 Infection. JNHRC 2020; 18 (1): 128-134. doi: 10.33314/jnhrc.v18i1.2608.
Coronavirus (COVID-19) Mortality Rate. Available at https://www.worldometers.info/coronavirus/coronavirus-death-rate/ Accessed on October 17, 2020.
Profound Human Toll’ in Excess Deaths From COVID-19 Calculated in Two Studies - Medscape - Oct 12, 2020. https://www.medscape.com/viewarticle/938996
Excess mortality from the Coronavirus pandemic (COVID-19) https://ourworldindata.org/excess-mortality-covid. Accessed on July 12, 2020
Are New COVID-19 Treatments More Important Than a Vaccine? - Medscape - Oct 06, 2020. https://www.medscape.com/viewarticle/938578.
Center for Disease Control and Prevention. Coronavirus Disease 2019- Clinical Care Guidance updated June 30, 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html Accessed on July 11, 2020
Saurabh Jha. John Ioannidis Explains His COVID Views - Medscape - Jul 15, 2020 https://www.medscape.com/viewarticle/933977. Accessed on July 30, 2020
COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed on July 11, 2020.
WHO I Country & Technical Guidance - Coronavirus disease (COVID-19). [Internet] WHO. World Health Organization. Available at:
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance Accessed on July 11, 2020.
Copyright (c) 2021 Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in EJMS are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). The author(s) as the copyright holder will retain the ownership of the copyrights without any restrictions for their content under the CC-BY 4.0 license, and allow others to copy, use, print, share, modify, and distribute the content of the article even in commercial purpose as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers. Appropriate attribution can be provided by simply citing the original article.
On behalf of all the authors, the corresponding author is responsible for completing and returning the agreement form to the editorial office. More information about the terms and conditions, privacy policies, and copyrights can be found on the webpage of the Creative Commons license privacy policy. https://creativecommons.org/licenses/by/4.0/